Menu
GWAS Study

Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.

Shiraishi K, Okada Y, Takahashi A et al.

27501781 PubMed ID
GWAS Study Type
18331 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SK
Shiraishi K
OY
Okada Y
TA
Takahashi A
KY
Kamatani Y
MY
Momozawa Y
AK
Ashikawa K
KH
Kunitoh H
MS
Matsumoto S
TA
Takano A
SK
Shimizu K
GA
Goto A
TK
Tsuta K
WS
Watanabe SI
OY
Ohe Y
WY
Watanabe Y
GY
Goto Y
NH
Nokihara H
FK
Furuta K
YA
Yoshida A
GK
Goto K
HT
Hishida T
TM
Tsuboi M
TK
Tsuchihara K
MY
Miyagi Y
NH
Nakayama H
YT
Yokose T
TK
Tanaka K
NT
Nagashima T
OY
Ohtaki Y
MD
Maeda D
IK
Imai K
MY
Minamiya Y
SH
Sakamoto H
SA
Saito A
SY
Shimada Y
SK
Sunami K
SM
Saito M
IJ
Inazawa J
NY
Nakamura Y
YT
Yoshida T
YJ
Yokota J
MF
Matsuda F
MK
Matsuo K
DY
Daigo Y
KM
Kubo M
KT
Kohno T
Chapter II

Abstract

Summary of the research findings

Lung adenocarcinoma driven by somatic EGFR mutations is more prevalent in East Asians (30-50%) than in European/Americans (10-20%). Here we investigate genetic factors underlying the risk of this disease by conducting a genome-wide association study, followed by two validation studies, in 3,173 Japanese patients with EGFR mutation-positive lung adenocarcinoma and 15,158 controls. Four loci, 5p15.33 (TERT), 6p21.3 (BTNL2), 3q28 (TP63) and 17q24.2 (BPTF), previously shown to be strongly associated with overall lung adenocarcinoma risk in East Asians, were re-discovered as loci associated with a higher susceptibility to EGFR mutation-positive lung adenocarcinoma. In addition, two additional loci, HLA class II at 6p21.32 (rs2179920; P =5.1 × 10(-17), per-allele OR=1.36) and 6p21.1 (FOXP4) (rs2495239; P=3.9 × 10(-9), per-allele OR=1.19) were newly identified as loci associated with EGFR mutation-positive lung adenocarcinoma. This study indicates that multiple genetic factors underlie the risk of lung adenocarcinomas with EGFR mutations.

663 Japanese ancestry cases, 4,367 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

18331
Total Participants
GWAS
Study Type
Yes
Replicated
2,510 Japanese ancestry cases, 10,791 Japanese ancestry controls
Replication Participants
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.